For the Inventor, By the Inventor

Enter assignee name

Societe Civile Bioprojet

Calculating rank

USPTO Granted Patents = 20

% Expired Patents = 5.0

Forward Citations = 472

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Jean-Charles Schwartz (18 out of 62 patents)

Jeanne-Marie Lecomte (17 out of 56 patents)

Denis Danvy (10 out of 21 patents)

4. Lucette Duhamel (9 out of 28 patents)

5. Pierre Duhamel (9 out of 31 patents)

6. Claude Gros (8 out of 12 patents)

7. Jean-Christophe Plaquevent (8 out of 12 patents)

8. Jean-Michel Arrang (7 out of 13 patents)

9. Monique Garbarg (7 out of 12 patents)

10. Thierry Monteil (6 out of 12 patents)

11. Bruno Giros (4 out of 8 patents)

12. Holger Stark (4 out of 9 patents)

13. Walter Schunack (4 out of 17 patents)

14. Charon R Ganellin (4 out of 153 patents)

15. Ralph Lipp (3 out of 19 patents)

20 patents: Sort by Forward Citations

1. 7910605 - [object Object] (2011-03-22),

2. 7138413 - [object Object] (2006-11-21),

3. 6013829 - Process for the asymmetric synthesis of S-acyl derivatives of (2000-01-11),

4. 5985895 - 2-naphthamide derivatives and their therapeutic applications (1999-11-16),

5. 5846956 - Amino acids derivatives, the process for their preparation and their (1998-12-08),

6. 5786494 - Process for the synthesis of .alpha.-substituted acrylic acids and their (1998-07-28),

7. 5708171 - Imidazole derivatives for pharmaceutical use (1998-01-13),

8. 5670531 - Amino acid derivatives, the process for their preparation and their (1997-09-23),

9. 5646313 - Amino acid derivatives, processes for their preparation and their (1997-07-08),

10. 5599951 - Amino acid derivatives, the process for their preparation and their (1997-02-04),

11. 5559113 - Imidazole compounds and their therapeutic applications (1996-09-24),

12. 5342960 - Azomethines agonist compounds of the histamine H.sub.3 receptor for (1994-08-30),

13. 5331008 - Thioester enantiomeric compounds and their therapeutic uses (1994-07-19),

14. 5321039 - Method of inducing a histamine agonist action on H.sub.2 receptors (1994-06-14),

15. 5296509 - Thioester enantiomeric compounds and their therapeutic uses (1994-03-22),

Company Overview

Societe Civile Bioprojet is a Paris-based organization specializing in the development and commercialization of innovative biopharmaceutical products. The company focuses on research in the fields of drug delivery systems and therapeutic solutions, particularly in the areas of pain management and addiction treatment. With a commitment to advancing healthcare, Bioprojet collaborates with various stakeholders to enhance patient outcomes through its cutting-edge technologies and scientific expertise.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

20 Patents

#239 in Paris

#1,014 in France

#31,296 in the World

Societe Civile Bioprojet

Forward Citations = 472

40 inventors:

Jean-Charles Schwartz (18 out of 62 patents)

Jeanne-Marie Lecomte (17 out of 56 patents)

Denis Danvy (10 out of 21 patents)

4. Lucette Duhamel (9 out of 28 patents)

5. Pierre Duhamel (9 out of 31 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Societe Civile Bioprojet. Retrieved from https://idiyas.com/company/societe-civile-bioprojet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…